Clinical Minds Knowledge Base
Welcome to Medidata’s resource for news media and others who want to learn more.
Clinical Minds Knowledge Base is starting with a focus on Decentralized Clinical Trials (DCTs). These remote technology solutions helped to propel clinical trials during the COVID-19 pandemic, while patients faced quarantines and lock downs. DCTs have surged in use over the past few years and have been ensuring patients, medical staff, and pharmaceutical, vaccine, and medical device innovators can engage in more meaningful and productive ways.
Please see the resources below for information and subscribe to receive the latest news by visiting the Medidata Newsroom.
Decentralized Clinical Trials
In recent years, decentralization of clinical trial activities has emerged as one of the fastest growing and most essential trends in clinical research. The decentralized clinical trial (DCT) market is projected to reach $16.29 billion in value by 2027.
The pandemic emphasized the crucial role clinical trial technology must play in helping trial operators facilitate studies off-site, as sponsors and contract research organizations (CROs) pivoted towards solutions that would help them conduct and administer remote clinical trials.
The resources below offer information and insights into how the life sciences industry is leveraging decentralized clinical trials to help maintain and accelerate the development of new therapeutics, vaccines, and medical devices to benefit patients worldwide. See our glossary for key terms, DCT Trends and Stats for key industry data points, and a compelling case study to learn about one of the largest and first decentralized trials.
Contact Medidata DCT Experts
Additional Assets
The Value of Decentralized Clinical Trials
The world of clinical research has seen a pronounced shift in how clinical trials are conducted. Hear from Anthony Costello, CEO of Medidata, as he discusses with Harvard Business Review what DCTs mean for patients, doctors, and pharmaceutical companies.
DCT Case Study
The ADAPTABLE Aspirin study not only helped determine dosing for daily aspirin regimens, it is the largest 100% virtual clinical trial conducted to date. Learn more about this pioneering decentralized trial study. Registration required.
Medidata Secures Top Honors in Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, has again been recognized as a Leader in Everest Group’s recently published “Decentralized Clinical Trials Platforms PEAK Matrix® Assessment 2023.” Medidata was the only provider to receive a “Star Performer” designation for the second consecutive year, reflecting its continued innovation and leadership.